This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohana, S.
Right arrow Articles by Lawrence, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohana, S.
Right arrow Articles by Lawrence, C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 2005, p. 2095-2097, Vol. 49, No. 5
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.5.2095-2097.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Spread of a Klebsiella pneumoniae Strain Producing a Plasmid- Mediated ACC-1 AmpC ß-Lactamase in a Teaching Hospital Admitting Disabled Patients

Salomon Ohana,1 Veronique Leflon,2 Esthel Ronco,1 Martin Rottman,1 Didier Guillemot,3 Sylvie Lortat-Jacob,4 Pierre Denys,4 Georges Loubert,5 Marie-Helène Nicolas-Chanoine,2 Jean-Louis Gaillard,1 and Christine Lawrence1*

Laboratoire de microbiologie, Hôpital Raymond Poincaré, Assistance Publique—Hôpitaux de Paris, 92380 Garches, France,1 Laboratoire de microbiologie, Hôpital Ambroise Paré, Assistance Publique—Hôpitaux de Paris, 92104 Boulogne, France,2 Unité des agents antibactériens, Institut Pasteur, 75015 Paris, France,3 Département de médecine physique et réadaptation, Hôpital Raymond Poincaré, Assistance Publique—Hôpitaux de Paris, 92380 Garches, France,4 Département de réanimation chirurgicale, Hôpital Raymond Poincaré, Assistance Publique—Hôpitaux de Paris, 92380 Garches, France5

Received 7 September 2004/ Returned for modification 7 October 2004/ Accepted 12 January 2005


arrow
ABSTRACT
 
We describe a large outbreak involving a Klebsiella pneumoniae strain producing a plasmid-encoded ACC-1 type AmpC ß-lactamase in a hospital caring for patients with motor impairment. The epidemic strain was isolated from 57 patients in six wards between September 1999 and May 2003 and caused clinical infections in 19 patients.


arrow
TEXT
 
Large nosocomial epidemics involving AmpC-producing Klebsiella pneumoniae strains have never been reported to date. The first reported nosocomial outbreak due to AmpC-producing K. pneumoniae strains occurred at the Miriam Hospital (Rhodes, Greece) in 1988 and involved 11 patients (8). A number of other outbreaks have since been described, but they rarely involved more than 10 individuals (7). We report the largest outbreak involving a plasmid-encoded AmpC-producing K. pneumoniae strain and the first such case in a department of physical medicine and rehabilitation (PMR).

The Raymond Poincaré hospital (Garches, France) is a 440-bed teaching hospital that includes a 150-bed PMR department caring for patients with motor impairment. In November 1999, a 26-year-old patient with tetraplegia transferred from Tunisia to the PMR department was found to have urine samples positive for an ACC-1-producing K. pneumoniae strain. After the identification of three other cases from January to March 2000 in the PMR department, the screening policy used for the detection of extended-spectrum ß-lactamase-producing organisms by rectal swabbing and inoculation of Drigalski agar plates containing 0.5 ml/liter of cefotaxime (1) was extended to ACC-1-producing K. pneumoniae strains. Oxidase-negative colonies detected on cefotaxime selection plates were tested with the disk diffusion method (3) for susceptibility to ticarcillin-clavulanate, ceftazidime, cefotaxime, aztreonam, cefepime, cefoxitin, and cefotetan. Epidemic ACC-1-producing K. pneumoniae was suspected in the presence of the susceptibility pattern shown in Fig. 1.



View larger version (169K):
[in this window]
[in a new window]
  		FIG. 1. ß-Lactam susceptibility pattern of the epidemic ACC-1-producing K. pneumoniae strain (disk diffusion method on Mueller-Hinton agar). Note the following: (i) the resistance to cefotaxime, ceftazidime, aztreonam, and cefotetan; (ii) the susceptibility to cefepime and cefoxitin; (iii) the lack of synergy between ceftazidime, cefotaxime, aztreonam, cefepime, and clavulanate; (iv) the inhibition zone of cefoxitin was greater than that of cefotetan (diameters of 19 to 25 mm versus 16 to 20 mm, respectively) and antagonism between cefoxitin and clavulanate. Abbreviations: TCC, ticarcillin-clavulanate; CAZ, ceftazidime; FOX, cefoxitin; FEP, cefepime; ATM, aztreonam; CTX, cefotaxime; and CTT, cefotetan.

The epidemic involved a total of 57 cases (at least one clinical sample and/or rectal swab positive for ACC-1-producing K. pneumoniae) from September 1999 to May 2003, mainly in the PMR department (46 cases) but also in other hospital units (surgical intensive care unit, 7 cases; medical intensive care unit, 3 cases; and septic orthopedic surgery, 1 case). The epidemic was controlled by strictly isolating carriers of ACC-1-producing K. pneumoniae, a measure implemented only at a late stage because it is in contradiction with our reeducation strategy. ACC-1-producing K. pneumoniae isolates were detected in diagnostic cultures (12 cases), screening cultures (24 cases), or both (21 cases). Nineteen patients met the criteria for nosocomial infection (4) (urinary tract infection, 16 cases; pyelonephritis with bloodstream infection, 2 cases; and paravertebral abscess, 1 case). The mean (± the standard deviation) delay between admission and the first positive sample was 28 (±40) days (range, 1 to 229 days). Most patients were male (sex ratio, 0.86). The median age was 34 years (range, 17 to 94 years). All patients had a neurological disease, mostly spinal cord injury.

All ACC-1-producing K. pneumoniae isolates collected during the outbreak showed the same pattern of resistance to ß-lactams with the disk diffusion method and were resistant to gentamicin, tobramycin, netilmicin, trimethoprim-sulfamethoxazole, and rifampin; most isolates were resistant to tetracycline and/or intermediate or resistant to ciprofloxacin. MICs of ceftazidime, cefotaxime, cefoxitin, cefotetan, and cefepime were determined by the agar dilution method on the first ACC-1-producing K. pneumoniae isolates recovered from cases 1 to 12. The results confirmed the results of previous disk diffusion susceptibility tests (Table 1) and suggested the presence of an AmpC-type enzyme, most likely an ACC-1 enzyme because of the susceptibility to cefoxitin (2).


View this table:
[in this window]
[in a new window]
  		TABLE 1. ß-Lactam susceptibility of epidemic ACC-1-producing K. pneumoniae

The first isolates recovered from cases 1, 2, and 3 (referred to as isolates 1, 2, and 3, respectively) were each tested for the ability to transfer ceftazidime resistance to Escherichia coli K12C600 (Strr) by conjugation and to E. coli NM554 (Strr) by transformation. Transconjugants and transformants were selected on Drigalski agar plates containing streptomycin (100 mg/liter) and ceftazidime (10 mg/liter). Transconjugants (obtained only with isolate 2) and transformants displayed the same pattern of resistance to ß-lactam agents as the donor K. pneumoniae isolates. Other resistance markers were cotransferred: (i) gentamicin, tobramycin, and netilmicin (isolates 1, 2, and 3); (ii) rifampin (isolates 1, 2, and 3); (iii) sulfamethoxazole (isolates 1 and 2); (iv) trimethoprim (isolate 3); and (v) tetracycline (isolate 3). Each of the transconjugants and transformants contained a single additional plasmid of approximately 100 kb (data not shown), suggesting that all of the transferred resistance genes were carried by this genetic element.

PCR was carried out on the epidemic K. pneumoniae isolates 1 to 3 and their transconjugants and transformants in E. coli using the sets of primers ACC3-ACC2, SHV01-SHV02, and TEMA1-TEMB1 (Table 2). The amplification conditions were 45 cycles of 30 s at 94°C, 30 s at the annealing temperature, and 30 s at 72°C and a final extension step at 72°C for 10 min. The PCR products were sequenced with the Big Dye terminator sequencing kit (Perkin-Elmer/Applied Biosystems, Courtaboeuf, France) using the primers listed in Table 2 and an ABI Prism sequencer (Perkin-Elmer/Applied Biosystems). The three K. pneumoniae isolates and their transconjugants and transformants yielded an amplicon of 1,276 bp with the primer set ACC3-ACC2, which was identical to the first ACC-1 K. pneumoniae gene described (2). PCR studies also revealed the presence of a blaSHV gene in epidemic K. pneumoniae isolates but not in the transconjugants and transformants and of a blaTEM gene, identified as a blaTEM1B (Pa/Pb) gene by sequencing, both in the epidemic isolates and in their transconjugants and transformants.


View this table:
[in this window]
[in a new window]
  		TABLE 2. Primers used for PCR and sequencing

ACC-1-producing K. pneumoniae isolates were characterized by random amplified polymorphic DNA (RAPD) and pulsed-field gel electrophoresis (PFGE) analysis of XbaI-digested DNA. RAPD was carried out as previously described using the primers HLWL74 (5'-ACGTATCTGC-3') and R108 (5'-GTATTGCCCT-3') (5). PFGE was carried out using the GenePath system with a CHEF DRII apparatus (Bio-Rad Laboratories, Marnes-la-Coquette, France), as previously described (13). All of the epidemic ACC-1-producing K. pneumoniae isolates analyzed shared the same RAPD profile and were of the same PFGE pulsotype according to Tenover et al. (13) (data not shown).

This is the first large, nosocomial outbreak involving a unique strain of K. pneumoniae producing a plasmid-mediated AmpC ß-lactamase. The epidemic strain harbored a plasmid-borne blaACC-1 gene, known to be derived from the chromosomal bla gene of Hafnia alvei (9). This strain was imported from a region of Tunisia that constitutes a persistent focus of multidrug-resistant K. pneumoniae strains, including strains harboring the plasmid-borne blaACC-1 gene (11). The fact that our institution is geared toward the rehabilitation of patients with motor impairment probably strongly affected the dissemination of the strain in an endemic-epidemic manner, with transfers and prolonged stays of patients providing mobile reservoirs for bacteria (6).


arrow
ACKNOWLEDGMENTS
 
We thank S. Geoffroy, C. Wippf, and I. Sénegas for their contribution to this work.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Laboratoire de microbiologie, Hôpital Raymond Poincaré, 104 Boulevard Raymond Poincaré, 92380 Garches, France. Phone: 33 1 47 10 77 25. Fax: 33 1 47 10 79 49. E-mail: christine.lawrence{at}rpc.ap-hop-paris.fr. Back


arrow
REFERENCES
 
    1
  1. Astagneau, P., Y. Costa, P. Legrand, J. Lucet, L. Marty, and B. Prieur. 1999. Maitrise de la diffusion des bactéries multirésistantes aux antibiotiques. Comité Technique National des Infections Nosocomiales, Paris, France.
    2. 2
  2. Bauernfeind, A., I. Schneider, R. Jungwirth, H. Sahly, and U. Ullmann. 1999. A novel type of AmpC ß-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia. Antimicrob. Agents Chemother. 43:1924-1931.[Abstract/Free Full Text]
    3. 3
  3. Cavallo, J. D., H. Chardon, C. Chidiac, P. Choutet, P. Courvalin, H. Dabernat, H. Drugeon, L. Dubreuil, F. Goldstein, V. Jarlier, R. Leclercq, M. H. Nicolas, A. Philippon, C. Quentin, B. Rouveix, J. Sirot, and C. J. Soussy. 2004. Communiqué 2004. Comité de l'antibiogramme de la Société Française de Microbiologie, Paris, France.
    4. 4
  4. Garner, J. S., W. R. Jarvis, T. G. Emori, T. C. Horan, and J. M. Hughes. 1988. CDC definitions for nosocomial infections, 1988. Am. J. Infect. Control 16:128-140.[CrossRef][Medline]
    5. 5
  5. Gori, A., F. Espinasse, A. Deplano, C. Nonhoff, M. H. Nicolas, and M. J. Struelens. 1996. Comparison of pulsed-field gel electrophoresis and randomly amplified DNA polymorphism analysis for typing extended-spectrum-ß-lactamase-producing Klebsiella pneumoniae. J. Clin. Microbiol. 34:2448-2453.[Abstract]
    6. 6
  6. Mangeney, N., P. Niel, G. Paul, E. Faubert, S. Hue, C. Dupeyron, F. Louarn, and G. Leluan. 2000. A 5-year epidemiological study of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a medium- and long-stay neurological unit. J. Appl. Microbiol. 88:504-511.[CrossRef][Medline]
    7. 7
  7. Nadjar, D., M. Rouveau, C. Verdet, L. Donay, J. Herrmann, P. H. Lagrange, A. Philippon, and G. Arlet. 2000. Outbreak of Klebsiella pneumoniae producing transferable AmpC-type beta-lactamase (ACC-1) originating from Hafnia alvei. FEMS Microbiol. Lett. 187:35-40.[Medline]
    8. 8
  8. Papanicolaou, G. A., A. A. Medeiros, and G. A. Jacoby. 1990. Novel plasmid-mediated ß-lactamase (MIR-1) conferring resistance to oxyimino- and {alpha}-methoxy ß-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 34:2200-2209.[Abstract/Free Full Text]
    9. 9
  9. Philippon, A., G. Arlet, and G. A. Jacoby. 2002. Plasmid-determined AmpC-type ß-lactamases. Antimicrob. Agents Chemother. 46:1-11.[Free Full Text]
    10. 10
  10. Pitout, J. D., K. S. Thomson, N. D. Hanson, A. F. Ehrhardt, E. S. Moland, and C. C. Sanders. 1998. ß-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob. Agents Chemother. 42:1350-1354.[Abstract/Free Full Text]
    11. 11
  11. Rhimi-Mahjoubi, F., M. Bernier, G. Arlet, Z. B. Jemaa, P. Jouve, A. Hammami, and A. Philippon. 2002. Identification of plasmid-encoded cephalosporinase ACC-1 among various enterobacteria (Klebsiella pneumoniae, Proteus mirabilis, Salmonella) isolated from a Tunisian hospital (Sfax 997-2000). Pathol. Biol. (Paris) 50:7-11. (In French.)[Medline]
    12. 12
  12. Speldooren, V., B. Heym, R. Labia, and M.-H. Nicolas-Chanoine. 1998. Discriminatory detection of inhibitor-resistant ß-lactamases in Escherichia coli by single-strand conformation polymorphism-PCR. Antimicrob. Agents Chemother. 42:879-884.[Abstract/Free Full Text]
    13. 13
  13. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.[Medline]

Antimicrobial Agents and Chemotherapy, May 2005, p. 2095-2097, Vol. 49, No. 5
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.5.2095-2097.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Jacoby, G. A. (2009). AmpC {beta}-Lactamases. Clin. Microbiol. Rev. 22: 161-182 [Abstract] [Full Text]  
  • Papagiannitsis, C. C., Tzouvelekis, L. S., Tzelepi, E., Miriagou, V. (2007). Plasmid-Encoded ACC-4, an Extended-Spectrum Cephalosporinase Variant from Escherichia coli. Antimicrob. Agents Chemother. 51: 3763-3767 [Abstract] [Full Text]  
  • Doloy, A., Verdet, C., Gautier, V., Decre, D., Ronco, E., Hammami, A., Philippon, A., Arlet, G. (2006). Genetic Environment of Acquired blaACC-1 {beta}-Lactamase Gene in Enterobacteriaceae Isolates. Antimicrob. Agents Chemother. 50: 4177-4181 [Abstract] [Full Text]  
  • Ruppe, E., Bidet, P., Verdet, C., Arlet, G., Bingen, E. (2006). First Detection of the Ambler Class C 1 AmpC {beta}-Lactamase in Citrobacter freundii by a New, Simple Double-Disk Synergy Test. J. Clin. Microbiol. 44: 4204-4207 [Abstract] [Full Text]  
  • Verdet, C., Benzerara, Y., Gautier, V., Adam, O., Ould-Hocine, Z., Arlet, G. (2006). Emergence of DHA-1-Producing Klebsiella spp. in the Parisian Region: Genetic Organization of the ampC and ampR Genes Originating from Morganella morganii. Antimicrob. Agents Chemother. 50: 607-617 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohana, S.
Right arrow Articles by Lawrence, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohana, S.
Right arrow Articles by Lawrence, C.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»